21685538|changes|C0392747^C0443172|start=0|end=7|CONC
21685538|serum|C0229671^C1546774^C1550100|start=11|end=16|ANAT^CONC
21685538|levels|C0441889|start=17|end=23|CONC
21685538|fragments|C0332255^C0486805|start=38|end=47|CONC^ANAT
21685538|hepatitis b|C0019163|start=51|end=62|DISO
21685538|negative|C2825415^C0205160^C2825491|start=73|end=81|CONC
21685538|chronic hepatitis b|C0524909|start=82|end=101|DISO
21685538|oral|C1527415^C0226896^C0442027|start=117|end=121|CONC^ANAT
21685538|antiviral therapy|C0280274|start=122|end=139|PROC
21685538|background|C1706907|start=141|end=151|CONC
21685538|effect|C2348382^C1280500|start=157|end=163|CONC
21685538|chronic hepatitis b|C0524909|start=167|end=186|DISO
21685538|chb|C0151517|start=188|end=191|DISO
21685538|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=193|end=202|PROC^CONC
21685538|hepatocyte apoptosis|C3269241|start=206|end=226|PHYS
21685538|evaluated|C0220825|start=240|end=249|PROC
21685538|investigated|C1292732|start=254|end=266|CONC
21685538|changes|C0392747^C0443172|start=271|end=278|CONC
21685538|serum|C0229671^C1546774^C1550100|start=282|end=287|ANAT^CONC
21685538|levels|C0441889|start=288|end=294|CONC
21685538|apoptotic|C1516044|start=302|end=311|CONC
21685538|generated|C3146294|start=320|end=329|ACTI
21685538|fragments|C0332255^C0486805|start=330|end=339|CONC^ANAT
21685538|hepatitis b|C0019163|start=364|end=375|DISO
21685538|hbeag|C0201483|start=387|end=392|PROC
21685538|negative|C2825415^C0205160^C2825491|start=394|end=402|CONC
21685538|chb|C0151517|start=403|end=406|DISO
21685538|methods|C0025664^C0449851^C0025663|start=457|end=464|CONC
21685538|included|C0332257|start=469|end=477|CONC
21685538|hbeag|C0201483|start=495|end=500|PROC
21685538|negative|C2825415^C0205160^C2825491|start=501|end=509|CONC
21685538|chb|C0151517|start=510|end=513|DISO
21685538|received|C1514756|start=522|end=530|CONC
21685538|months|C0439231|start=576|end=582|CONC
21685538|treated|C1522326|start=605|end=612|CONC
21685538|virological|C0205466|start=636|end=647|CONC
21685538|breakthroughs|C0444503|start=648|end=661|CONC
21685538|received|C1514756|start=666|end=674|CONC
21685538|therapy|C0039798^C0087111|start=691|end=698|PROC^CONC
21685538|months|C0439231|start=709|end=715|CONC
21685538|levels|C0441889|start=717|end=723|CONC
21685538|fragments|C0332255^C0486805|start=732|end=741|CONC^ANAT
21685538|measured|C3541902^C0444706|start=747|end=755|PROC^CONC
21685538|stored|C1698986|start=767|end=773|CONC
21685538|serum|C0229671^C1546774^C1550100|start=774|end=779|ANAT^CONC
21685538|elisa|C0014441|start=819|end=824|PROC
21685538|kit|C1705213^C1705212^C1150635^C1553450^C0812225^C3273202^C1416655^C1704888^C0920288^C1690540|start=825|end=828|GENE^PHYS^OBJC^DEVI^CONC
21685538|alexis|C0445425|start=838|end=844|CONC
21685538|germany|C0017480|start=856|end=863|GEOG
21685538|initial|C1279901^C1705685^C1705684^C1555582^C0205265|start=882|end=889|CONC
21685538|therapy|C0039798^C0087111|start=890|end=897|PROC^CONC
21685538|median|C0876920^C2347635^C2939193^C0549183^C2348144|start=903|end=909|CONC
21685538|serum k|C0302353|start=910|end=917|PROC
21685538|fragment|C1708096^C0332255^C0486805|start=921|end=929|CONC^ANAT
21685538|levels|C0441889|start=930|end=936|CONC
21685538|reduced|C0392756|start=956|end=963|CONC
21685538|baseline|C1442488^C1552824|start=969|end=977|CONC
21685538|months|C0439231|start=1005|end=1011|CONC
21685538|months|C0439231|start=1058|end=1064|CONC
21685538|fragment|C1708096^C0332255^C0486805|start=1100|end=1108|CONC^ANAT
21685538|levels|C0441889|start=1109|end=1115|CONC
21685538|increased|C0442805^C0205217|start=1116|end=1125|CONC
21685538|breakthroughs|C0444503|start=1129|end=1142|CONC
21685538|compared|C1707455|start=1165|end=1173|ACTI
21685538|previous|C0205156^C1552607|start=1182|end=1190|CONC
21685538|visits|C0545082^C1512346|start=1191|end=1197|PROC^ACTI
21685538|lower|C1548802^C0441994^C2003888|start=1240|end=1245|ACTI^ANAT^CONC
21685538|baseline|C1442488^C1552824|start=1251|end=1259|CONC
21685538|changes|C0392747^C0443172|start=1271|end=1278|CONC
21685538|fragment|C1708096^C0332255^C0486805|start=1287|end=1295|CONC^ANAT
21685538|levels|C0441889|start=1296|end=1302|CONC
21685538|correlated|C1707520|start=1303|end=1313|CONC
21685538|changes|C0392747^C0443172|start=1330|end=1337|CONC
21685538|alanine aminotransferase|C0201836|start=1341|end=1365|PROC
21685538|alt|C2257651^C0201836|start=1367|end=1370|PROC^PHYS
21685538|hbv|C0019163|start=1376|end=1379|DISO
21685538|baseline|C1442488^C1552824|start=1389|end=1397|CONC
21685538|months|C0439231|start=1409|end=1415|CONC
21685538|initial|C1279901^C1705685^C1705684^C1555582^C0205265|start=1419|end=1426|CONC
21685538|therapy|C0039798^C0087111|start=1427|end=1434|PROC^CONC
21685538|breakthroughs|C0444503|start=1453|end=1466|CONC
21685538|fragment|C1708096^C0332255^C0486805|start=1473|end=1481|CONC^ANAT
21685538|levels|C0441889|start=1482|end=1488|CONC
21685538|trend|C1521798|start=1500|end=1505|CONC
21685538|decrease|C0392756^C0547047|start=1516|end=1524|CONC
21685538|addition|C0332287^C1883712|start=1539|end=1547|CONC
21685538|months|C0439231|start=1575|end=1581|CONC
21685538|months|C0439231|start=1630|end=1636|CONC
21685538|conclusions|C1707478|start=1667|end=1678|CONC
21685538|serum|C0229671^C1546774^C1550100|start=1680|end=1685|ANAT^CONC
21685538|levels|C0441889|start=1686|end=1692|CONC
21685538|fragments|C0332255^C0486805|start=1701|end=1710|CONC^ANAT
21685538|decrease|C0392756^C0547047|start=1711|end=1719|CONC
21685538|oral|C1527415^C0226896^C0442027|start=1741|end=1745|CONC^ANAT
21685538|antiviral therapy|C0280274|start=1746|end=1763|PROC
21685538|hbeag|C0201483|start=1767|end=1772|PROC
21685538|negative|C2825415^C0205160^C2825491|start=1773|end=1781|CONC
21685538|chb|C0151517|start=1782|end=1785|DISO
21685538|parallel|C2348042^C2826345|start=1789|end=1797|PROC^CONC
21685538|alt|C2257651^C0201836|start=1823|end=1826|PROC^PHYS
21685538|hbv|C0019163|start=1831|end=1834|DISO
21685538|levels|C0441889|start=1839|end=1845|CONC
21685538|increased|C0442805^C0205217|start=1852|end=1861|CONC
21685538|breakthroughs|C0444503|start=1875|end=1888|CONC
21685538|improved|C0184511^C1561611^C0332272|start=1893|end=1901|CONC
21685538|effective|C1704419^C1280519|start=1911|end=1920|CONC
21685538|therapy|C0039798^C0087111|start=1928|end=1935|PROC^CONC
21685538|rate|C1521828^C0871208^C1549480|start=1957|end=1961|ACTI^CONC
21685538|compared|C1707455|start=1962|end=1970|ACTI
21685538|initial|C1279901^C1705685^C1705684^C1555582^C0205265|start=1978|end=1985|CONC
21685538|therapy|C0039798^C0087111|start=1986|end=1993|PROC^CONC
